(Stroke. 1997;28:1783-1788.)
© 1997 American Heart Association, Inc.
Articles |
Intravenous Thrombolysis With Recombinant Staphylokinase Versus Tissue-Type Plasminogen Activator in a Rabbit Embolic Stroke Model
From the Center for Molecular and Vascular Biology, University of Leuven, Belgium.
Correspondence to Désiré Collen, MD, PhD, Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, O & N, Herestraat 49, B-3000 Leuven, Belgium. E-mail Desire.Collen{at}med.kuleuven.ac.be
Background and Purpose Timely intravenous administration of recombinant tissue-type plasminogen activator (alteplase, rTPA) to patients with evolving ischemic stroke improves neurological outcome. The present study was designed to compare the effects of rTPA and recombinant staphylokinase (Sak), a highly fibrin-specific thrombolytic agent, in an experimental model of rabbit embolic stroke.
Methods Groups of 5 to 12 rabbits were given intravenous saline or heparin and aspirin with, in addition, either Sak (1 or 2 mg/kg infused over 30 minutes or 2 mg/kg injected over 1 minute) or rTPA (3 or 6 mg/kg infused over 30 minutes or 6 mg/kg injected over 1 minute). Infusions were started 15 minutes after selective injection of standardized 125I-fibrin labeled rabbit plasma clots into the internal carotid artery.
Results Mean clot lysis over 60 minutes increased from 3.8% after saline to between 27% and 44% after Sak regimens (P=.0001 versus control) and to between 15% and 34% after rTPA regimens (P=.0001). Median volume of the ischemic lesion at 5 hours decreased from 190 mm3 after saline to between 11 and 17 mm3 after Sak (P=.02) and to between 0.5 to 54 mm3 after rTPA (P=.04). Mean neurological impairment at 5 hours (on a scale of 0 to 3) decreased from 2.3 after saline to between 1.3 to 1.6 after Sak (P=.003) and to between 1.1 to 1.9 after rTPA (P=.02). At the highest doses used, fibrinogen depletion was marginal with Sak but total with rTPA. Marked prolongation of ear puncture and cuticle bleeding times was only observed after bolus administration of rTPA.
Conclusions In the present rabbit model of embolic stroke, Sak was significantly more fibrin-specific than rTPA and at least as effective in lysing arterial emboli and limiting ischemia and neurological impairment.
Key Words: thrombolytic therapy • cerebral ischemia • rabbits • animal models
This article has been cited by other articles:
 |
|
 |
|
  K. Kirchhof, T. Welzel, S. Zoubaa, C. Lichy, M. Sikinger, H. L. de Ruiz, and K. Sartor New Method of Embolus Preparation for Standardized Embolic Stroke in Rabbits Stroke, September 1, 2002; 33(9): 2329 - 2333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nagai, M. De Mol, B. Van Hoef, M. Verstreken, and D. Collen Depletion of circulating {alpha}2-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization Blood, May 15, 2001; 97(10): 3086 - 3092. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nagai, I. Vanlinthout, and D. Collen Comparative Effects of Tissue Plasminogen Activator, Streptokinase, and Staphylokinase on Cerebral Ischemic Infarction and Pulmonary Clot Lysis in Hamster Models Circulation, December 21, 1999; 100(25): 2541 - 2546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagai, M. De Mol, H. R. Lijnen, P. Carmeliet, and D. Collen Role of Plasminogen System Components in Focal Cerebral Ischemic Infarction : A Gene Targeting and Gene Transfer Study in Mice Circulation, May 11, 1999; 99(18): 2440 - 2444. [Abstract] [Full Text] [PDF]
|
|